Yamazato M, Muratani H, Fukiyama K
Third Department of Internal Medicine, University of the Ryukyus School of Medicine.
Nihon Rinsho. 1997 Aug;55(8):1971-6.
Evidence suggests the existence of a Na,K-ATPase inhibitor, so called endogenous digitalis-like factor (EDLF), in plasma. This substance has been postulated to enhance renal tubular sodium excretion and to increase peripheral vascular resistance. Recently, plant ouabain or its isomer (ouabain-like compound, OLC) was purified from human plasma and bovine hypothalamic extract. The OLC is considered to be a candidate for the EDLF. The OLC has been implicated in the pathogenesis of sodium-dependent hypertension. Furthermore, accumulating evidence suggests central nervous system as a site of hypertensinogenic action of OLC.
有证据表明血浆中存在一种钠钾-ATP酶抑制剂,即所谓的内源性洋地黄样因子(EDLF)。据推测,这种物质可增强肾小管钠排泄并增加外周血管阻力。最近,从人血浆和牛下丘脑提取物中纯化出了植物哇巴因或其异构体(类哇巴因化合物,OLC)。OLC被认为是EDLF的一个候选物。OLC与钠依赖性高血压的发病机制有关。此外,越来越多的证据表明中枢神经系统是OLC产生致高血压作用的部位。